scPharmaceuticals Inc.
SCPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$85,148 | -$54,810 | -$36,838 | -$28,034 |
| Dep. & Amort. | $20 | $626 | $468 | $438 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,442 | $4,856 | $2,838 | $2,366 |
| Change in WC | -$13,092 | -$6,321 | -$350 | -$2,599 |
| Other Non-Cash | $22,240 | -$3,595 | -$695 | $678 |
| Operating Cash Flow | -$70,538 | -$59,244 | -$34,577 | -$27,151 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$21 | -$40 | -$21 | -$9 |
| Net Acquisitions | $0 | $0 | $45,838 | -$32,139 |
| Inv. Purchases | $0 | -$50,595 | -$67,538 | -$9,011 |
| Inv. Sales/Matur. | $29,320 | $70,600 | $21,700 | $41,150 |
| Other Inv. Act. | $0 | $0 | -$45,838 | $32,139 |
| Investing Cash Flow | $29,299 | $19,965 | -$45,859 | $32,130 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,228 | $0 | $29,801 | -$2,500 |
| Stock Issued | $53,547 | $14,038 | $47,765 | $51 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $19,761 | $812 | -$337 | -$81 |
| Financing Cash Flow | $70,080 | $14,850 | $77,229 | -$2,530 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $28,841 | -$24,429 | -$3,207 | $2,449 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,814 | $71,243 | $74,450 | $72,001 |
| End Cash | $75,655 | $46,814 | $71,243 | $74,450 |
| Free Cash Flow | -$70,559 | -$59,284 | -$34,598 | -$27,160 |